Literature DB >> 6640554

Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.

E T Creagan, A J Schutt, J N Ingle, J R O'Fallon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6640554

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study.

Authors:  D D Von Hoff; S J Green; J A Neidhart; C Fabian; T Budd; J F Boyd; C K Osborne
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

Review 2.  Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.

Authors:  Joseph R Bertino; William R Waud; William B Parker; Martin Lubin
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

3.  A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.

Authors:  Hedy Lee Kindler; Howard A Burris; Alan B Sandler; Ira Anton Oliff
Journal:  Invest New Drugs       Date:  2008-07-11       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.